Year |
Citation |
Score |
2023 |
Le Guern R, Grandjean T, Stabler S, Bauduin M, Gosset P, Kipnis É, Dessein R. Gut colonisation with multidrug-resistant Klebsiella pneumoniae worsens Pseudomonas aeruginosa lung infection. Nature Communications. 14: 78. PMID 36604442 DOI: 10.1038/s41467-022-35767-4 |
0.431 |
|
2022 |
Louis M, Clamens T, Tahrioui A, Desriac F, Rodrigues S, Rosay T, Harmer N, Diaz S, Barreau M, Racine PJ, Kipnis E, Grandjean T, Vieillard J, Bouffartigues E, Cornelis P, et al. Pseudomonas aeruginosa Biofilm Dispersion by the Human Atrial Natriuretic Peptide. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 9: e2103262. PMID 35032112 DOI: 10.1002/advs.202103262 |
0.31 |
|
2020 |
Dessein R, Bauduin M, Grandjean T, Le Guern R, Figeac M, Beury D, Faure K, Faveeuw C, Guery B, Gosset P, Kipnis E. Antibiotic-related gut dysbiosis induces lung immunodepression and worsens lung infection in mice. Critical Care (London, England). 24: 611. PMID 33076936 DOI: 10.1186/s13054-020-03320-8 |
0.637 |
|
2019 |
Bortolotti P, Kipnis E, Faure E, Faure K, Wacrenier A, Fauquembergue M, Penven M, Messaadi S, Marceau L, Dessein R, Le Guern R. Clostridium ventriculi bacteremia following acute colonic pseudo-obstruction: A case report. Anaerobe. 59: 32-34. PMID 31103530 DOI: 10.1016/J.Anaerobe.2019.05.005 |
0.31 |
|
2018 |
Bortolotti P, Faure E, Kipnis E. Inflammasomes in Tissue Damages and Immune Disorders After Trauma. Frontiers in Immunology. 9: 1900. PMID 30166988 DOI: 10.3389/Fimmu.2018.01900 |
0.353 |
|
2017 |
Prevotat A, Rouyer C, Gosset P, Kipnis E, Faure K, Guery B. Biphasic lung injury during Streptococcus pneumoniae infection in a murine model. Medecine Et Maladies Infectieuses. PMID 29191391 DOI: 10.1016/J.Medmal.2017.11.001 |
0.403 |
|
2016 |
Bortolotti P, Hennart B, Thieffry C, Jausions G, Faure E, Grandjean T, Thepaut M, Dessein R, Allorge D, Guery BP, Faure K, Kipnis E, Toussaint B, Le Gouellec A. Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship. Bmc Microbiology. 16: 137. PMID 27392067 DOI: 10.1186/S12866-016-0756-X |
0.643 |
|
2016 |
Faure E, Bortolotti P, Kipnis E, Faure K, Guery B. Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways. Journal of Visualized Experiments : Jove. PMID 26863066 DOI: 10.3791/53218 |
0.651 |
|
2015 |
Thépaut M, Grandjean T, Hober D, Lobert PE, Bortolotti P, Faure K, Dessein R, Kipnis E, Guery B. Protective role of murine norovirus against Pseudomonas aeruginosa acute pneumonia. Veterinary Research. 46: 91. PMID 26338794 DOI: 10.1186/S13567-015-0239-3 |
0.656 |
|
2014 |
Boukerb AM, Rousset A, Galanos N, Méar JB, Thépaut M, Grandjean T, Gillon E, Cecioni S, Abderrahmen C, Faure K, Redelberger D, Kipnis E, Dessein R, Havet S, Darblade B, et al. Antiadhesive properties of glycoclusters against Pseudomonas aeruginosa lung infection. Journal of Medicinal Chemistry. 57: 10275-89. PMID 25419855 DOI: 10.1021/Jm500038P |
0.734 |
|
2014 |
Faure E, Mear JB, Faure K, Normand S, Couturier-Maillard A, Grandjean T, Balloy V, Ryffel B, Dessein R, Chignard M, Uyttenhove C, Guery B, Gosset P, Chamaillard M, Kipnis E. Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome. American Journal of Respiratory and Critical Care Medicine. 189: 799-811. PMID 24555512 DOI: 10.1164/Rccm.201307-1358Oc |
0.713 |
|
2014 |
Faure E, Poissy J, Goffard A, Fournier C, Kipnis E, Titecat M, Bortolotti P, Martinez L, Dubucquoi S, Dessein R, Gosset P, Mathieu D, Guery B. Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside? Plos One. 9: e88716. PMID 24551142 DOI: 10.1371/Journal.Pone.0088716 |
0.576 |
|
2014 |
Mear JB, Gosset P, Kipnis E, Faure E, Dessein R, Jawhara S, Fradin C, Faure K, Poulain D, Sendid B, Guery B. Candida albicans airway exposure primes the lung innate immune response against Pseudomonas aeruginosa infection through innate lymphoid cell recruitment and interleukin-22-associated mucosal response. Infection and Immunity. 82: 306-15. PMID 24166952 DOI: 10.1128/Iai.01085-13 |
0.728 |
|
2013 |
Méar JB, Kipnis E, Faure E, Dessein R, Schurtz G, Faure K, Guery B. Candida albicans and Pseudomonas aeruginosa interactions: more than an opportunistic criminal association? Medecine Et Maladies Infectieuses. 43: 146-51. PMID 23622953 DOI: 10.1016/J.Medmal.2013.02.005 |
0.612 |
|
2012 |
Kipnis É, Dessein R, Faure K, Guery B. Les thérapeutiques anti-infectieuses non antibiotiques RéAnimation. 21: 303-316. DOI: 10.1007/S13546-012-0472-Y |
0.494 |
|
2011 |
Robriquet L, Kipnis E, Kipris E, Guery B. Beta-adrenergic modulation of lung fluid balance in acute P aeruginosa pneumonia in rats. Experimental Lung Research. 37: 453-60. PMID 21895446 DOI: 10.3109/01902148.2011.593092 |
0.58 |
|
2011 |
Ader F, Jawhara S, Nseir S, Kipnis E, Faure K, Vuotto F, Chemani C, Sendid B, Poulain D, Guery B. Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model. Critical Care (London, England). 15: R150. PMID 21689424 DOI: 10.1186/Cc10276 |
0.61 |
|
2011 |
Le Berre R, Nguyen S, Nowak E, Kipnis E, Pierre M, Quenee L, Ader F, Lancel S, Courcol R, Guery BP, Faure K. Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia. Critical Care Medicine. 39: 2113-20. PMID 21572326 DOI: 10.1097/Ccm.0B013E31821E899F |
0.56 |
|
2009 |
Ganter MT, Roux J, Su G, Lynch SV, Deutschman CS, Weiss YG, Christiaans SC, Myazawa B, Kipnis E, Wiener-Kronish JP, Howard M, Pittet JF. Role of small GTPases and alphavbeta5 integrin in Pseudomonas aeruginosa-induced increase in lung endothelial permeability. American Journal of Respiratory Cell and Molecular Biology. 40: 108-18. PMID 18703797 DOI: 10.1165/rcmb.2007-0454OC |
0.353 |
|
2008 |
Ader F, Le Berre R, Fackeure R, Raze D, Menozzi FD, Viget N, Faure K, Kipnis E, Guery B, Jarraud S, Etienne J, Chidiac C. In vivo effect of adhesion inhibitor heparin on Legionella pneumophila pathogenesis in a murine pneumonia model. Intensive Care Medicine. 34: 1511-9. PMID 18365173 DOI: 10.1007/S00134-008-1063-2 |
0.582 |
|
2008 |
Mokart D, Kipnis E, Guerre-Berthelot P, Vey N, Capo C, Sannini A, Brun JP, Blache JL, Mege JL, Blaise D, Guery BP. Monocyte deactivation in neutropenic acute respiratory distress syndrome patients treated with granulocyte colony-stimulating factor. Critical Care (London, England). 12: R17. PMID 18282280 DOI: 10.1186/Cc6791 |
0.546 |
|
2007 |
Kipnis E, Guery B, Wiener-Kronish J. Promises and limitations of the bronchoscopic microsampling probe. Chest. 132: 1414. PMID 17934140 DOI: 10.1378/Chest.07-0519 |
0.418 |
|
2007 |
Kipnis E, Guery B. Targeting lung coagulation disorders in acute lung injury: easy as pie (PAI-1)? Critical Care Medicine. 35: 1448-9; author reply. PMID 17446763 DOI: 10.1097/01.Ccm.0000262547.19416.3B |
0.566 |
|
2006 |
Kipnis E, Sawa T, Wiener-Kronish J. Targeting mechanisms of Pseudomonas aeruginosa pathogenesis. Medecine Et Maladies Infectieuses. 36: 78-91. PMID 16427231 DOI: 10.1016/J.MEDMAL.2005.10.007 |
0.372 |
|
2005 |
Ader F, Le Berre R, Faure K, Gosset P, Epaulard O, Toussaint B, Polack B, Nowak E, Viget NB, Kipnis E, Guery BP. Alveolar response to Pseudomonas aeruginosa: role of the type III secretion system. Infection and Immunity. 73: 4263-71. PMID 15972518 DOI: 10.1128/Iai.73.7.4263-4271.2005 |
0.388 |
|
2005 |
Boyer S, Faure K, Ader F, Husson MO, Kipnis E, Prangere T, Leroy X, Guery BP. Chronic pneumonia with Pseudomonas aeruginosa and impaired alveolar fluid clearance. Respiratory Research. 6: 17. PMID 15707485 DOI: 10.1186/1465-9921-6-17 |
0.59 |
|
2004 |
Kipnis E, Guery BP, Tournoys A, Leroy X, Robriquet L, Fialdes P, Neviere R, Fourrier F. Massive alveolar thrombin activation in Pseudomonas aeruginosa-induced acute lung injury. Shock (Augusta, Ga.). 21: 444-51. PMID 15087821 |
0.55 |
|
Show low-probability matches. |